Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2007 Aug;60(8):958.
doi: 10.1136/jcp.2006.042481.

Albumin-bound paclitaxel (ABI-007; Abraxane) in the management of basal-like breast carcinoma

Kadri Altundag, Didem S Dede, Tugrul Purnak
Comment

Albumin-bound paclitaxel (ABI-007; Abraxane) in the management of basal-like breast carcinoma

Kadri Altundag et al. J Clin Pathol. 2007 Aug.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Comment on

References

    1. Banerjee S, Reis‐Filho J S, Ashley S.et al Basal‐like breast carcinomas: clinical outcome and response to chemotherapy. J Clin Pathol 200659729–735. - PMC - PubMed
    1. Pinilla S M, Honrado E, Hardisson D.et al Caveolin‐1 expression is associated with a basal‐like phenotype in sporadic and hereditary breast cancer. Breast Cancer Res Treat 20069985–90. - PubMed
    1. Rouzier R, Perou C M, Symmans W F.et al Breast cancer molecular subtypes respond differently to preoperative chemotherapy. Clin Cancer Res 2005115678–5685. - PubMed
    1. Gradishar W J, Tjulandin S, Davidson N.et al Superior efficacy of albumin‐bound paclitaxel, ABI‐007, compared with polyethylated castor oil‐based paclitaxel in women with metastatic breast cancer: results of a phase III trial. J Clin Oncol 2005237794–7803. - PubMed
    1. Desai N, Yao Z, Trieu V.et al Evidence of greater antitumor activity of Cremophor‐free nanoparticle albumin‐bound (nab) paclitaxel (Abraxane) compared to Taxol: role of a novel albumin transporter mechanism. Presented at the 26th Annual San Antonio Breast Cancer Symposium; San Antonio, TX, December 20033–6.

MeSH terms